Loading...
Germlining of the HIV-1 broadly neutralizing antibody domain m36
Engineered antibody domains (eAds) have emerged as a novel class of HIV-1 inhibitors and are currently under preclinical testing as promising drug candidates for prevention and therapy of HIV-1 infection. Reverse mutation of antibodies to germline sequences (germlining) could not only identify less...
Na minha lista:
| Udgivet i: | Antiviral Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357557/ https://ncbi.nlm.nih.gov/pubmed/25676867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.02.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|